Literature DB >> 2736222

Natural resistance in mice against Friend cells injected intravenously. III. Comparison between in vivo and in vitro passaged interferon-sensitive (745) and interferon-resistant (3Cl8) cell clones.

M Neri1, T Zei, E Bonmassar, G B Rossi, G Fiorucci, A N Iorio.   

Abstract

In vitro (FLC-Vt) or in vivo (FLC-V) passaged Friend erythroleukaemia cells of DBA/2 origin were tested for susceptibility to natural resistance (NR) in vivo or to NK cell activity in vitro. Scarcely oncogenic FLC-Vt cells were highly susceptible to in vivo NR (measured as rapid organ clearance or growth inhibition in lethally irradiated mice) or to in vitro NK attack. Conversely, highly oncogenic FLC-V cells were weakly susceptible to NR and to NK as well. These data seem to point out that natural immunity, which is up-regulated by endogenous or exogenous interferons, can play a significant role in surveillance against mouse leukaemic cells of retrovirus origin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2736222      PMCID: PMC2246741          DOI: 10.1038/bjc.1989.181

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  Direct and indirect effects of interferon on in vivo murine tumor cell growth.

Authors:  K Uno; S Shimizu; M Ido; K Naito; K Inaba; T Oku; T Kishida; S Muramatsu
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

2.  31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.

Authors:  E Proietti; G Carpinelli; M Di Vito; F Belardelli; I Gresser; F Podo
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

3.  Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes.

Authors:  Y Kawano; K Taniguchi; A Toshitani; K Nomoto
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

4.  Natural cell-mediated cytotoxicity: a micro assay suitable for clinical tests.

Authors:  L Tentori; E Alvino; M P Fuggetta; S D'Atri; M G Giganti; R Caliendo; E Bonmassar
Journal:  Chemioterapia       Date:  1985-12

Review 5.  Interferons with special emphasis on the immune system.

Authors:  R M Friedman; S N Vogel
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

6.  Biologic and biochemical differences between in vitro and in vivo passaged Friend erythroleukemia cells. II. Changes in cell surface glycoproteins associated with a highly malignant phenotype.

Authors:  C Amici; M Ferrantini; A Benedetto; F Belardelli; I Gresser
Journal:  Int J Cancer       Date:  1984-09-15       Impact factor: 7.396

7.  Kinetic analysis of target cell destruction by effector T cells. I. Delineation of parameters related to the frequency and lytic efficiency of killer cells.

Authors:  R M Thorn; C S Henney
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

8.  Development of highly immunogenic variants of a rat fibrosarcoma line during in vitro cultivation.

Authors:  K Yamashina; T Oikawa; M Kasai; M Naiki; I Chiba; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  Relative contribution of antiproliferative and host immunity-associated activity of mouse interferon in murine tumor therapy.

Authors:  T Kataoka; F Oh-hashi; Y Sakurai; K Usuki; N Ida
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

10.  Biologic and biochemical differences between in vitro and in vivo passaged Friend erythroleukemia cells. I. Tumorigenicity and capacity to metastasize.

Authors:  F Belardelli; M Ferrantini; C Maury; L Santurbano; I Gresser
Journal:  Int J Cancer       Date:  1984-09-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.